Eli Lilly (LLY) Q4 2023 Earnings Call Transcript

LLY earnings call for the period ending December 31, 2023.

Related Keywords

Germany ,China ,Taiwan ,Japan ,Australia ,Boone County ,Indiana ,United States ,Research Triangle Park ,North Carolina ,Canada ,Puerto Rico ,Poland ,Chinese ,David Risinger Leerink ,Eli Lilly ,Seamus Fernandez ,Dave Ricks ,America Merrill Lynch ,Terence Flynn Morgan Stanley ,Rajesh Kumar ,Trung Huynh ,Chris Schott Jpmorgan ,David Risinger ,Johna Norton ,Louise Chen ,Chris Shibutani Goldman Sachs ,Jake Van Naarden ,Versanis Bio ,James Shin ,Andrew Baum Citi ,Louise Chen Cantor Fitzgerald ,Andrew Baum ,Joe Fletcher ,Carter Gould Barclays ,Patrik Jonsson ,Seamus Fernandez Guggenheim ,Lauren Zierki ,Ilya Yuffa ,Dan Skovronsky ,Akash Tewari ,Mablink Biosciences ,Steve Scala ,Chris Schott ,Kerry Holford ,Geoff Meacham ,Evan Seigerman ,Tim Anderson ,Terence Flynn ,Chris Shibutani ,Carter Gould ,Mike Springnether ,Mohit Bansal ,Akash Tewari Jefferies ,Kerry Holford Berenberg ,Anne White ,Morgan Stanley ,Company Analyst ,Approval Program ,Barclays ,Amgen ,Wolfe Research ,Tim Anderson Wolfe Research Analyst ,James Shin Deutsche Bank Analyst ,Wells Fargo ,Deutsche Bank ,Geoff Meacham Bank ,Exchange Commission ,Cigna ,Carolina Or Research Triangle Park ,Goldman Sachs ,Elilly International ,Vice President ,Anat Ashkenazi ,Lilly United ,Michaela Irons ,Motley Fool Stock Advisor ,Stock Advisor ,Chief Executive ,Emergence Therapeutics ,For Japan ,Accelerated Approval Program ,Scientific Officer ,Project Optimus ,Lilly Diabetes ,Umer Raffat ,Fargo Securities ,Medicare Part ,Capital Markets ,Whati Ve ,Maybei Ll ,Wells Fargo Securities ,Cantor Fitzgerald ,Berenberg Capital Markets ,Leerink Partners , ,